If You Invested in Kailera Therapeutics (KLRA)
Looking for the current price? See the KLRA quote & overviewWhat $1,000 or $10,000 in KLRA Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Apr 17, 2026 |
|---|---|---|---|---|
| $1,000 | — | — | — | $708 -29% |
| $10,000 | — | — | — | $7,081 -29% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for KLRA$1,000 Investment Over Time
KLRA vs S&P 500Year-by-Year Returns
KLRA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2026 | $26.00 | $18.41 | -29.2% | -29.2% |
About Kailera Therapeutics
Pharmaceutical Preparations · NASDAQ
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company developing product candidates for obesity care. The company is focused on a pipeline intended to provide treatment options for people living with obesity, with development work centered on GLP-1 based mechanisms of action and multiple routes of administration. Its common stock trades on the Nasdaq Global Select Market under the symbol KLRA.
The company describes an obesity-first development strategy built around four clinical-stage product candidates. Its pipeline focus places Kailera in the biotechnology segment of metabolic and obesity therapeutics, where company value is tied to the advancement, regulatory development, financing, and potential commercialization of investigational medicines rather than to an established commercial product portfolio.
Kailera operates as a public operating company headquartered in Waltham, Massachusetts. The company completed its initial public offering in April 2026, selling common stock and listing on Nasdaq. Public-company records identify Kailera as an emerging growth company and show a Delaware corporate structure with common stock registered under Section 12(b) of the Exchange Act.
As a newly public clinical-stage biotechnology issuer, Kailera's corporate profile is defined by its obesity-focused research and development activities, equity-financed capital structure, public-market listing, and governance framework for a development-stage life sciences company.
Frequently Asked Questions
Kailera Therapeutics investment returns
How much would $1,000 invested in Kailera Therapeutics be worth today?
Limited historical data is available for KLRA. The stock has been trading since 2026-04-17.
Has Kailera Therapeutics outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare KLRA performance over available time periods.
What is Kailera Therapeutics's average annual return?
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
